236 related articles for article (PubMed ID: 9337611)
1. Meso-tetraphenylporphyrin dimer derivative as a potential photosensitizer in photodynamic therapy.
Faustino MA; Neves MG; Vicente MG; Cavaleiro JA; Neumann M; Brauer HD; Jori G
Photochem Photobiol; 1997 Oct; 66(4):405-12. PubMed ID: 9337611
[TBL] [Abstract][Full Text] [Related]
2. meso-tetraphenylporphyrin dimer derivatives as potential photosensitizers in photodynamic therapy. Part 2.
Faustino MA; Neves MG; Cavaleiro JA; Neumann M; Brauer HD; Jori G
Photochem Photobiol; 2000 Aug; 72(2):217-25. PubMed ID: 10946576
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and tumour-photosensitizing properties of the cationic porphyrin meso-tetra(4N-methylpyridyl)porphine.
Villanueva A; Jori G
Cancer Lett; 1993 Sep; 73(1):59-64. PubMed ID: 8402599
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy.
Asano R; Nagami A; Fukumoto Y; Yazama F; Ito H; Sakata I; Tai A
Bioorg Med Chem; 2013 Apr; 21(8):2298-2304. PubMed ID: 23477944
[TBL] [Abstract][Full Text] [Related]
5. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H
Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472
[TBL] [Abstract][Full Text] [Related]
7. Sites of photodamage in vivo and in vitro by a cationic porphyrin.
Kessel D; Woodburn K; Henderson BW; Chang CK
Photochem Photobiol; 1995 Nov; 62(5):875-81. PubMed ID: 8570726
[TBL] [Abstract][Full Text] [Related]
8. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy.
Chen JJ; Hong G; Gao LJ; Liu TJ; Cao WJ
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1553-61. PubMed ID: 25609073
[TBL] [Abstract][Full Text] [Related]
10. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity.
Hilmey DG; Abe M; Nelen MI; Stilts CE; Baker GA; Baker SN; Bright FV; Davies SR; Gollnick SO; Oseroff AR; Gibson SL; Hilf R; Detty MR
J Med Chem; 2002 Jan; 45(2):449-61. PubMed ID: 11784149
[TBL] [Abstract][Full Text] [Related]
11. Silylation improves the photodynamic activity of tetraphenylporphyrin derivatives in vitro and in vivo.
Horiuchi H; Hosaka M; Mashio H; Terata M; Ishida S; Kyushin S; Okutsu T; Takeuchi T; Hiratsuka H
Chemistry; 2014 May; 20(20):6054-60. PubMed ID: 24710805
[TBL] [Abstract][Full Text] [Related]
12. Tetraphenylporphyrin derivatives possessing piperidine group as potential agents for photodynamic therapy.
Liao PY; Gao YH; Wang XR; Bao LL; Bian J; Hu TS; Zheng MZ; Yan YJ; Chen ZL
J Photochem Photobiol B; 2016 Dec; 165():213-219. PubMed ID: 27816643
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative.
Alvarez MG; Morán F; Yslas EI; Vittar NB; Bertuzzi M; Durantini EN; Rivarola V
Biomed Pharmacother; 2003; 57(3-4):163-8. PubMed ID: 12818478
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity evaluation of meso-tetra (pyrrolidine substituted) pentylporphin-mediated photodynamic therapy in vitro and in vivo.
Zhang LJ; Zhang XH; Liao PY; Sun JJ; Wang L; Yan YJ; Chen ZL
J Photochem Photobiol B; 2016 Oct; 163():224-31. PubMed ID: 27591565
[TBL] [Abstract][Full Text] [Related]
16. Photosensitizing effectiveness of a novel chlorin-based photosensitizer for photodynamic therapy in vitro and in vivo.
Zhang LJ; Bian J; Bao LL; Chen HF; Yan YJ; Wang L; Chen ZL
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1527-36. PubMed ID: 24863752
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy.
Bourré L; Simonneaux G; Ferrand Y; Thibaut S; Lajat Y; Patrice T
J Photochem Photobiol B; 2003 Mar; 69(3):179-92. PubMed ID: 12695032
[TBL] [Abstract][Full Text] [Related]
18. Selective antitumor effect of novel protease-mediated photodynamic agent.
Choi Y; Weissleder R; Tung CH
Cancer Res; 2006 Jul; 66(14):7225-9. PubMed ID: 16849570
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.
Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2017 Feb; 22(2):28002. PubMed ID: 28301655
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
